CoreCap Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
CoreCap Advisors's FBT Position: Q3 2026 in Review
CoreCap Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 136 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.
CoreCap Advisors first reported a position in FBT in Q4 2021 and has held it in 13 quarters since. The position peaked at $142K in Q4 2021. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- CoreCap Advisors held 136 shares of First Trust NYSE Arca Biotechnology Index Fund worth $37K as of Q3 2026.
- CoreCap Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1536 holding.
- CoreCap Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 13 quarters since.
- CoreCap Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $142K in Q4 2021.
- 98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.